Collectively, the results suggested that MET signaling was stimulated in the absence of CYP1A2, and the increased proliferation, migration, and invasion capacities could be reversed by MET inhibition in HCC cells in vitro. This evidence concerns the gene MET and hepatocellular carcinoma.